| Value | ₹100.0 Cr |
|---|
BSE filing, NSE: RLFL. Summary written from the filing by ALFA Finder's alert engine.
Raama Finance Ltd: key numbers
- Share price
- ₹9.02
- Market cap
- ₹73.21 Cr
- Revenue (annual)
- ₹12.06 Cr
- Net profit (annual)
- ₹3.24 Cr
- P/E (TTM)
- 9.9×Sector 19.8×
- Promoter holding
- 49.06%-5.87% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raama Finance Ltd
All →Raama Finance Other Announcement
Raama Finance appointed M/s. Kumar Gaurav & Co. as statutory auditor for three months effective October 29, 2026. The routine appointment carries no financial impact.
Raama Finance Convertible Warrants
Raama Finance approved conversion of 1,01,50,000 preferential warrants into equity shares, raising ₹4.87 Crore. The Board also appointed new statutory auditors in casual vacancy.
- Value
- ₹4.87 Cr
Raama Finance Other Announcement
The company submitted its quarterly shareholding pattern under SEBI Regulation 31 for the period ended September 30, 2026.
Raama Finance Management Change
Raama Finance Limited informed the exchange about the resignation of its Statutory Auditor, M/s. Goyal Nagpal and Co., effective from October 06, 2026.
Raama Finance Annual General Meeting
Raama Finance held its 33rd Annual General Meeting on September 30, 2026. Shareholders discussed and approved the company's financial statements and the re-appointment of a director.
Raama Finance Investor Presentation: Key Takeaways
Raama Finance reported strong Q1FY27 results, transitioning to a fully digital AI-driven lending model targeting the salaried workforce. Revenue reached ₹21.31 Cr, exceeding the entirety of FY26.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.